ACLX
Price
$100.64
Change
-$5.89 (-5.53%)
Updated
Nov 12, 03:14 PM (EDT)
128 days until earnings call
MGTX
Price
$6.76
Change
-$0.34 (-4.79%)
Updated
Nov 12, 03:29 PM (EDT)
120 days until earnings call
Ad is loading...

ACLX vs MGTX

Header iconACLX vs MGTX Comparison
Open Charts ACLX vs MGTXBanner chart's image
Arcellx
Price$100.64
Change-$5.89 (-5.53%)
Volume$500
CapitalizationN/A
MeiraGTx Holdings
Price$6.76
Change-$0.34 (-4.79%)
Volume$100
CapitalizationN/A
ACLX vs MGTX Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ACLX vs. MGTX commentary
Nov 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and MGTX is a Buy.

COMPARISON
Comparison
Nov 12, 2024
Stock price -- (ACLX: $106.53 vs. MGTX: $7.10)
Brand notoriety: ACLX and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 121% vs. MGTX: 166%
Market capitalization -- ACLX: $5.76B vs. MGTX: $548.01M
ACLX [@Biotechnology] is valued at $5.76B. MGTX’s [@Biotechnology] market capitalization is $548.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $476.71B to $0. The average market capitalization across the [@Biotechnology] industry is $2.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MGTX is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while MGTX’s TA Score has 6 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 4 bearish.
  • MGTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а +23.24% price change this week, while MGTX (@Biotechnology) price change was +19.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.03%. For the same industry, the average monthly price growth was +12.72%, and the average quarterly price growth was +8.80%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

MGTX is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (+2.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($5.76B) has a higher market cap than MGTX($548M). ACLX YTD gains are higher at: 91.946 vs. MGTX (1.140). ACLX has higher annual earnings (EBITDA): -46.86M vs. MGTX (-65.93M). ACLX has more cash in the bank: 517M vs. MGTX (100M). ACLX has less debt than MGTX: ACLX (74.3M) vs MGTX (87.6M). ACLX has higher revenues than MGTX: ACLX (145M) vs MGTX (8.12M).
ACLXMGTXACLX / MGTX
Capitalization5.76B548M1,051%
EBITDA-46.86M-65.93M71%
Gain YTD91.9461.1408,068%
P/E RatioN/AN/A-
Revenue145M8.12M1,785%
Total Cash517M100M517%
Total Debt74.3M87.6M85%
FUNDAMENTALS RATINGS
MGTX: Fundamental Ratings
MGTX
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXMGTX
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
75%
Bearish Trend 20 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WAUSX16.550.15
+0.91%
Wasatch US Select Investor
SBMLX25.620.21
+0.83%
ClearBridge Mid Cap C
FUNYX38.64N/A
N/A
Pioneer Fundamental Growth Y
GSTRX10.17N/A
N/A
Goldman Sachs Strategic Growth R
MMBUX14.69N/A
N/A
MassMutual Select TRP Sm&Mid Cap Blend I

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CRSP. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+3.37%
CRSP - ACLX
49%
Loosely correlated
+6.28%
BEAM - ACLX
48%
Loosely correlated
+12.27%
RCUS - ACLX
48%
Loosely correlated
-0.56%
RCKT - ACLX
46%
Loosely correlated
-3.50%
MGTX - ACLX
46%
Loosely correlated
+2.60%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+2.60%
NTLA - MGTX
52%
Loosely correlated
+4.66%
BEAM - MGTX
49%
Loosely correlated
+12.27%
EDIT - MGTX
48%
Loosely correlated
+5.77%
CRSP - MGTX
47%
Loosely correlated
+6.28%
AVIR - MGTX
46%
Loosely correlated
-4.57%
More